Open AccessCost‐effectiveness analysis of a randomized clinical trial of early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration
Author(s) -
Epstein D. M.,
Gohel M. S.,
Heatley F.,
Liu X.,
Bradbury A.,
Bulbulia R.,
Cullum N.,
Nyamekye I.,
Poskitt K. R.,
Renton S.,
Warwick J.,
Davies A. H.
Publication year - 2019
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1002/bjs.11082
Subject(s) - medicine , reflux , randomized controlled trial , cost effectiveness , surgery , quality of life (healthcare) , ablation , cost effectiveness analysis , quality adjusted life year , disease , risk analysis (engineering) , nursing
Treatment of superficial venous reflux in addition to compression therapy accelerates venous leg ulcer healing and reduces ulcer recurrence. The aim of this study was to evaluate the costs and cost-effectiveness of early versus delayed endovenous treatment of patients with venous leg ulcers.